G4Biotech

FRIENDS

G4 IN BIOTECH

We invest in greatest science, innovation and creativity around the world.

Sensible Biotechnologies develops a cell-based platform for producing high-quality mRNA, offering a scalable and cost-effective method for making vaccines and therapeutics. They are building a novel mRNA manufacturing paradigm to establish critical biomanufacturing infrastructure for global biosecurity.

A clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.

A biopharmaceutical company focused on developing a transformative new class of therapies that targets dysregulated differentiation and cellular plasticity for treating cancer.

BE Therapeutics (BE for Brain Engineering) is an innovative project developed within Apollo’s Venture Labs program. It aims to develop a cell therapy product capable of replacing damaged and aged brain tissue caused by conditions like stroke, traumatic brain injury, tumors, Parkinson’s, Alzheimer’s, and other neurodegenerative diseases.

Bloom Science is focused on targeting the gut-immune-brain axis by identifying specific microbial strains that may be associated with certain health outcomes.

Boosting cellular homeostasis to prevent and treat diseases of aging.

An early-stage platform company that combines mechano-biology and high content image analysis for the discovery of epigenetic modulators that drive cellular reprogramming and rejuvenation.

Galilei Biosciences is a drug development company targeting a central regulator of DNA damage repair, as well as glucose and lipid metabolism, driving metabolic health and human longevity.

A platform for the discovery and development of long-noncoding RNA targets for effective tissue-specific treatment of fibrotic diseases and other serious medical conditions.

MILES seeks to develop a fixed-dose combination of two or more active molecules that are already known to extend lifespan, based ondata from the Interventions Testing Program and other studies.

A pharmaceutical company discovering medicines to treat age-related diseases and extend the years of healthy living. Repair. Restore. Rejuvenate.

Biotech discovering new therapeutics for neurodegeneration and rare diseases by modulating the cellular process of autophagy.

Stemistry sets out to develop therapeutics capable of rejuvenating HSCs and consequently the entire immune system.

Thymofox focuses on identifying compounds that induce regeneration and rejuvenation of the thymus to restore thymus function in age-related diseases.

A data-driven precision medicine company, developing a deep proprietary and holistic dataset of various health parameters to enable the reliable discovery and validation of novel biomarkers.